What happens when a pharmaceutical drug does more harm than good? These stories about the Avandia diabetes drug may answer that question.

GSK Continues to Pay for Avandia Claims

Problems with Avandia continue to haunt GSK. Previously, GSK has settled thousands of claims over Avandia while claiming there is nothing wrong with the onetime diabetes wonder drug.  And now confronted with allegations brought by the State of Utah the drug giant defrauded the state’s Medicaid program through allegedly false and misleading marketing of Avandia, [...]

December 10th, 2013|Avandia Diabetes Drug, Drug and Medical Device Litigation|0 Comments

Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

Why Is the FDA Having Another Hearing on Avandia?

On June 5-6, 2013, the FDA will convene an advisory committee meeting on Avandia, a drug which was removed in most countries in 2010 and placed under severe restrictions in the US. Avandia, a project of GSK (GlaxoSmithkline), was the subject of extreme medical controversy and massive litigation in both the MDL and in State [...]

GSK Settles Avandia Governmental Probes for $3B, But Nothing For Consumers

Faced with multiple  criminal investigations into illegal practices, on November 3, 2011, the British drug company GlaxoSmithKline said that it had agreed to pay $3 billion to settle United States government civil and criminal investigations into its sales practices for numerous drugs, including Avandia. Company whisteblowers alleged that GSK improperly paid Doctors and manipulated medical [...]

November 4th, 2011|Avandia Diabetes Drug|0 Comments

New Study Links Avandia to Increased Risk of Blindness

A recent Bloomberg article discusses a new threat from taking Avandia: "People taking the drugs have a 3 to 6 times increased risk of developing diabetic macular edema, a condition in which the retina thickens and swells, according to a study of more than 100,000 people to be presented Sunday at the American Diabetes Association's [...]

June 27th, 2011|Avandia Diabetes Drug|0 Comments

FDA Orders Avandia to be Pulled from Pharmacy Shelves

Yesterday, the FDA ordered GlaxoSmithKline (GSK) to stop selling diabetes drug Avandia in retail pharmacies starting later this year. Once the best selling diabetes drug in the world with $3 billion in annual revenue, GSK still generated $680 million in Avandia sales last year even after the significant risks of this drug became known.  In [...]

May 19th, 2011|Avandia Diabetes Drug|0 Comments

Avandia Maker Seeks to Settle 1000 More Cases

A Bloomberg article reports that GlaxoSmithKline (GSK) is seeking to settle with 1000 patients who claim to be injured by the diabetes drug Avandia.  There are about 5300 cases pending in state courts concerning Avandia, which was pulled from the market in Europe and meant to be used only in limited cases in the United [...]

May 6th, 2011|Avandia Diabetes Drug|0 Comments

Louisiana Sues GSK for Avandia Fraud

Louisiana Attorney General Buddy Caldwell has filed suit in a Baton Rouge state court against GlaxoSmithKline claiming that it defrauded Louisiana's Medicaid program out of $36 million in reimbursement payments related to Avandia.  AG Caldwell contends that GSK "wrongfully and illegally marketed, priced, sold and promoted the diabetes medication".  Avandia use has been linked to [...]

February 18th, 2011|Avandia Diabetes Drug|0 Comments

FDA to Outsource Inspections of Non-U.S. Pharmaceutical Factories

With the advent of globalization and the move of manufacturing plants off shore, many drug manufacturers have taken advantage of lower costs and shipped American jobs overseas.  Unfortunately the FDA's U.S. based inspectors did not follow overseas to ensure the quality of the products manufacture for consumption in the U.S. In the U.S., FDA inspections [...]

Avandia Maker Sets Aside $3.4 Billion for Lawsuits

British drug manufacturer GlaxoSmithKline (GSK), which makes the recalled diabetes drug Avandia, has set aside a $3.4 billion "to pay for United States government investigations and product liability cases over its marketing of" Avandia. Click here to read the entire New York Times article. This set aside is in addition to the $2.36 billion charge [...]

January 21st, 2011|Avandia Diabetes Drug|0 Comments